causal

Biotech follows the capital cycle

The history of biotech is closely tied to the capital cycle, and Argenx's advantage lies in attracting long-term investors who will support the company through progress without forcing it to sacrifice its pipeline.

causalpending

Speaker

Julia

Evidence Quote

“the ability to attract long-term investors who are interested to supporting the company over the long term”

Source

Argenx: Changing Lives with Llamas— Business Breakdowns
Created: 11/17/2026, 3:39:21 AM

Your notes

Loading notes...